Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

BACKGROUND: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. METHODS: We analyzed surveillance data on inpatients younger than 21 years of age who had MIS-C and were admitted to 1 of 58 U.S. hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Mary Beth F., Murray, Nancy, Friedman, Kevin, Young, Cameron C., Newhams, Margaret M., Feldstein, Leora R., Loftis, Laura L., Tarquinio, Keiko M., Singh, Aalok R., Heidemann, Sabrina M., Soma, Vijaya L., Riggs, Becky J., Fitzgerald, Julie C., Kong, Michele, Doymaz, Sule, Giuliano, John S., Keenaghan, Michael A., Hume, Janet R., Hobbs, Charlotte V., Schuster, Jennifer E., Clouser, Katharine N., Hall, Mark W., Smith, Lincoln S., Horwitz, Steven M., Schwartz, Stephanie P., Irby, Katherine, Bradford, Tamara T., Maddux, Aline B., Babbitt, Christopher J., Rowan, Courtney M., McLaughlin, Gwenn E., Yager, Phoebe H., Maamari, Mia, Mack, Elizabeth H., Carroll, Christopher L., Montgomery, Vicki L., Halasa, Natasha B., Cvijanovich, Natalie Z., Coates, Bria M., Rose, Charles E., Newburger, Jane W., Patel, Manish M., Randolph, Adrienne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220972/
https://www.ncbi.nlm.nih.gov/pubmed/34133855
http://dx.doi.org/10.1056/NEJMoa2102605

Ejemplares similares

Ejemplares similares